Filters:
761 Projects | 523 Researchers | $306,533,976 Invested
2024
Johns Hopkins University
Jeffrey Rothstein, MD, PhD
Mitigating TDP-43 loss of function and disease initiation in FTD thru repair of the Nuclear Pore and CHMP7/ESCRT3 dysfunction.
2024
FINGERS Brain Health Institute
Miia Kivipelto, MD, PhD
Strategic Collaborative Framework for developing and testing innovative combination therapies, biomarkers, and digital solutions for precision prevention of cognitive decline and Alzheimer’s Disease and Related Dementias (previously: FINGERS Brain Health Institute - ADDF Memorandum of Understanding Planning Grant)
2024
University College London
Simon Mead, MD, FRCP, PhD
Biomarker-driven phenotyping for Alzheimer's disease and related dementia
2023
Metro International Biotech
David Livingston, PhD
Nicotinamide Mononucleotide in Patients with Alzheimer's Disease
2023
ADmit Therapeutics S.L.
Marta Barrachina, PhD, MBA
MAP-AD, a revolutionary Methylation Profiling approach for early diagnosis of Alzheimer’s Disease
2023
NeuroAge Therapeutics
Christin Glorioso, MD, PhD
A multi-omics brain aging test for tracking cognitive sharpness and risk of dementia
2023
Optina Diagnostics
Jean-Philippe Sylvestre, PEng, PhD
Clinical value evaluation of the awAIr(TM)-CAS test based on hyperspectral retinal imaging
2023
Virginia Commonwealth University
Shijun Zhang, PhD
Probing neuroinflammation in Alzheimer's with NLRP3 PET radiotracers
2023
Genuv Inc.
Sungho HAN
Preclinical study to explore the proof-of concept of trametinib at the lowest dose for the development of a disease-modifying treatment for Alzheimer’s disease
2023
GliaPharm SA
Pierre Magistretti, MD, PhD
IND-enabling studies for GliaPharm’s lead candidate to rescue hypometabolism in Alzheimer’s disease